BACKGROUND: Infections caused by extended-spectrum β-lactamase (ESBL)-producing
gram-negative bacilli constitute a growing problem worldwide. At the American University of …

Introduction: Bloodstream infection caused by extended-spectrum beta-lactamase (ESBL)-
producing pathogens has become a serious concern worldwide. The purpose of this study …

Background: To assess the prevalence of extended spectrum beta-lactamase (ESBL)
producing Escherichia coli and Klebsiella strains in nosocomial and community-acquired …

Objective To study the clinical characteristics and associated risk factors of infections caused
by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. Methods A case …

Background and objective: Extended-spectrum β-lactamase (ESBL)-producing organisms
have been reported among nosocomial pathogens. The objective of this study is to …

Abstract Background: In 1995, β-lactam inhibitor combinations replaced third-generation
cephalosporins as empirical therapy in an effort to manage extended-spectrum β-lactamase …

Background Community-associated infections caused by extended-spectrum beta-
lactamase (ESBL) producing bacteria are a growing concern. Methods Retrospective cohort …

Extended-spectrum b-lactamases (ESBLs) form a heterogeneous group that share the
property of hydrolytic activity against the oxyimino-b-lactams while remaining susceptible to …

Background: Production of extended spectrum beta-lactamase (ESbL) is one of the most
important resistance mechanisms that hamper the antimicrobial treatment of infections …

Extended-spectrum β-lactamase (ESBL)–producing bacteria are emerging pathogens. To
analyze risk factors for colonization with ESBL-producing bacteria at intensive care unit …